|
Combination of monalizumab and cetuximab in recurrent or metastatic head and neck cancer patients previously treated with platinum-based chemotherapy and PD-(L)1 inhibitors. |
|
|
Consulting or Advisory Role - Alkermes; AstraZeneca; Cantargia AB; Genocea Biosciences; Heat Biologics; Innate Pharma; Kyn therapeutics; Takeda |
Research Funding - Celldex (Inst); Genocea Biosciences (Inst); Heat Biologics (Inst); Innate Pharma (Inst); Kyn therapeutics (Inst); Merck (Inst); Xencor (Inst) |
Travel, Accommodations, Expenses - Alkermes; Genocea Biosciences; Heat Biologics; Innate Pharma; Kyn therapeutics; Takeda |
|
|
Consulting or Advisory Role - AstraZeneca; Bayer; Pfizer; Pfizer |
Travel, Accommodations, Expenses - Trident Pharmaceuticals |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Stock and Other Ownership Interests - Gilead Sciences |
Consulting or Advisory Role - Aduro Biotech; ATARA Biotherapeutics; COTA; CUE Biopharma; grand rounds; IQvia; IQvia; KeyQuest Health; Loxo; PDS Biotechnology; Pfizer; PRA Health Sciences; Rakuten Medical; Roche; Taiho Oncology |
Research Funding - Abbvie; AstraZeneca; Atara Biotherapeutics; Bristol-Myers Squibb; Cellsight Technologies; Cullinan Oncology; Exelixis; Innate Pharma; NIH/NCI; Novartis; Roche; Tessa Therapeutics |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Innate Pharma; Merck Serono; MSD |
Travel, Accommodations, Expenses - Merck Serono |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Promedior |
Consulting or Advisory Role - Cel-Sci; Merck |
Research Funding - advaxis (Inst); AstraZeneca (Inst); Formation Biologics (Inst); Hookipa Pharma; Innate Pharma (Inst); MedImmune (Inst) |
Patents, Royalties, Other Intellectual Property - anti-Pseudomonas antibody (Inst); anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Amgen; Merck; PFIZER |
|
|
Stock and Other Ownership Interests - SQZ Biotech |
Consulting or Advisory Role - AstraZeneca; Bayer; Cue Biopharma; Innate Pharma; Loxo; Maverick Therapeutics; Merck; Nanobiotix; Roche; SQZ Biotech |
Research Funding - AstraZeneca (Inst); BMS Brazil (Inst); Jounce Therapeutics (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - Innate Pharma; Merck |
|
|
Employment - Avalere Health (I) |
Stock and Other Ownership Interests - Inovalon (I) |
Consulting or Advisory Role - Prelude Therapeutics |
Patents, Royalties, Other Intellectual Property - Provisional patent filing for machine learning assets to aid cancer classification. |
Travel, Accommodations, Expenses - Sandbox Ventures |
|
|
Employment - Innate Pharma |
Stock and Other Ownership Interests - Innate Pharma |
Travel, Accommodations, Expenses - Innate Pharma |
|
|
Employment - Innate Pharma |
Stock and Other Ownership Interests - Innate Pharma |
Travel, Accommodations, Expenses - Innate Pharma |
|
|
Employment - Innate Pharma |
Stock and Other Ownership Interests - Innate Pharma |
Patents, Royalties, Other Intellectual Property - Innate Pharma |
Travel, Accommodations, Expenses - Innate Pharma |
|
|
Employment - Innate Pharma |
Stock and Other Ownership Interests - Innate Pharma |
Travel, Accommodations, Expenses - Innate Pharma |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Biogen; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Consulting or Advisory Role - AstraZeneca; BIOGEN; Bristol-Myers Squibb; Innate Pharma; Merck Serono; Merck Sharp & Dohme |
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme |